Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15505422

Download in:

View as

General Info

PMID
15505422